rs62635656
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM1PM5PP3PP5_Very_Strong
The NM_201253.3(CRB1):āc.3122T>Cā(p.Met1041Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00000682 in 1,614,008 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M1041V) has been classified as Pathogenic.
Frequency
Consequence
NM_201253.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CRB1 | NM_201253.3 | c.3122T>C | p.Met1041Thr | missense_variant | 9/12 | ENST00000367400.8 | NP_957705.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CRB1 | ENST00000367400.8 | c.3122T>C | p.Met1041Thr | missense_variant | 9/12 | 1 | NM_201253.3 | ENSP00000356370 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152214Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251068Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135678
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461676Hom.: 0 Cov.: 32 AF XY: 0.00000688 AC XY: 5AN XY: 727142
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152332Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74492
ClinVar
Submissions by phenotype
Leber congenital amaurosis 8 Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 20, 2024 | - - |
Pathogenic, no assertion criteria provided | research | Laboratory of Genetics in Ophthalmology, Institut Imagine | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
Retinitis pigmentosa 12 Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 01, 1999 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
Retinal dystrophy Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Blueprint Genetics | Nov 20, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | May 03, 2024 | Variant summary: CRB1 c.3122T>C (p.Met1041Thr) results in a non-conservative amino acid change located in the Laminin G domain (IPR001791) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.2e-05 in 251068 control chromosomes. c.3122T>C has been reported in the literature in multiple individuals affected with Retinal Dystrophy (Mathijssen_2017, DenHollander_1999). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 10508521, 27380427). ClinVar contains an entry for this variant (Variation ID: 5730). Based on the evidence outlined above, the variant was classified as pathogenic. - |
CRB1-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Aug 09, 2018 | Across a selection of the available literature, the CRB1 c.3122T>C (p.Met1041Thr) missense variant has been reported in at least three studies in which it is found in a homozygous state in total of 37 individuals from two large families, the majority of whom were described as being affected with autosomal recessive retinitis pigmentosa (arRP) (den Hollander et al. 1999; Hettinga et al. 2016; Mathijssen et al. 2016). The p.Met1041Thr variant was also detected in a heterozygous state in six unaffected parents of affected individuals. An additional individual with arRP was reportedly heterozygous for the p.Met1041Thr but also carried likely causative variants in other genes associated with arRP (Eisenberger et al. 2013). To date, this variant has not been reported in association with autosomal dominant retinal disorders or other autosomal recessive phenotypes. The p.Met1041Thr variant was reported in a heterozygous state in 16 of 940 controls and is reported at a frequency of 0.000027 in the European (non-Finnish) population of the Genome Aggregation Database. Based on the evidence, the p.Met1041Thr variant is classified as pathogenic for CRB1-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Retinitis pigmentosa 12;C3151202:Leber congenital amaurosis 8 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 21, 2023 | For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Met1041 amino acid residue in CRB1. Other variant(s) that disrupt this residue have been observed in individuals with CRB1-related conditions (PMID: 10508521, 30543658), which suggests that this may be a clinically significant amino acid residue. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CRB1 protein function. ClinVar contains an entry for this variant (Variation ID: 5730). This missense change has been observed in individual(s) with retinitis pigmentosa (PMID: 10508521, 27380427). It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs62635656, gnomAD 0.003%). This sequence change replaces methionine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 1041 of the CRB1 protein (p.Met1041Thr). - |
Pigmented paravenous retinochoroidal atrophy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
not provided Other:1
not provided, no classification provided | literature only | Retina International | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at